Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip De Keyser

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Clinical Chemistry and Laboratory Medicine|July 19, 2013
The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategiesCarolien Bonroy, Vanessa Smith, Katleen Van Steendam, et al.
The Journal of Rheumatology|November 3, 2012
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvementVanessa Smith, Yves Piette, Jens T van Praet, et al.
Rheumatology and Therapy|May 4, 2020
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic DiseasesHermine Leroi, Valérie Badot, Filip De Keyser, et al.
Vaccine|February 9, 2013
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccinesFernanda Tavares Da Silva, Filip De Keyser, Paul-Henri Lambert, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot studyVanessa Smith, Saskia Decuman, Alberto Sulli, et al.
The Journal of Pathology|April 6, 2005
Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritisLeen De Rycke, Dominique Baeten, Dirk Foell, et al.
Acta Clinica Belgica|April 15, 2016
The heart and pulmonary arterial hypertension in systemic sclerosisEls H Vandecasteele, Michel De Pauw, Guy Brusselle, et al.
Nature Reviews. Rheumatology|June 19, 2013
The influence of ageing on the development and management of rheumatoid arthritisAnnemieke M H Boots, Andrea B Maier, Piet Stinissen, et al.
Arthritis and Rheumatism|June 30, 2005
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritisLeen De Rycke, Dominique Baeten, Elli Kruithof, et al.
Drugs|November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitisFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Clinical Chemistry and Laboratory Medicine|July 19, 2013
The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategiesCarolien Bonroy, Vanessa Smith, Katleen Van Steendam, et al.
The Journal of Rheumatology|November 3, 2012
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvementVanessa Smith, Yves Piette, Jens T van Praet, et al.
Rheumatology and Therapy|May 4, 2020
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic DiseasesHermine Leroi, Valérie Badot, Filip De Keyser, et al.
Vaccine|February 9, 2013
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccinesFernanda Tavares Da Silva, Filip De Keyser, Paul-Henri Lambert, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot studyVanessa Smith, Saskia Decuman, Alberto Sulli, et al.
The Journal of Pathology|April 6, 2005
Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritisLeen De Rycke, Dominique Baeten, Dirk Foell, et al.
Acta Clinica Belgica|April 15, 2016
The heart and pulmonary arterial hypertension in systemic sclerosisEls H Vandecasteele, Michel De Pauw, Guy Brusselle, et al.
Nature Reviews. Rheumatology|June 19, 2013
The influence of ageing on the development and management of rheumatoid arthritisAnnemieke M H Boots, Andrea B Maier, Piet Stinissen, et al.
Arthritis and Rheumatism|June 30, 2005
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritisLeen De Rycke, Dominique Baeten, Elli Kruithof, et al.
Drugs|November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitisFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Pageof 11